Federal Register Notice: FDA is requesting that any industry organizations interested in participating in the selection of a nonvoting industry representative to serve on CBER’s Blood Products Advisory Committee notify the agency in writing. FDA is also requesting nominations for a nonvoting industry representative to serve on the Blood Products Advisory Committee. To view this notice, click here.
